Cell-Wave Study: Combined Extracorporal Shock Wave Therapy and Intracoronary Cell Therapy in Chronic Ischemic Myocardium

Inclusion Criteria: * Patients with chronic ischemic heart disease * Patients with anterior myocardial infarction \> 3months * EF \< 50% or NYHA II-IV * Age 18-80 * Informed consent Exclusion Criteria: * Ventricular thrombus * Infarct \< 3 months. * Active infection or fever * Chronic inflammatory disease (e.g M. Crohn, Rheumatoid Arthritis) * HIV Infection oder active Hepatitis * Neoplastic disease w/o complete remission within 5 years * Stroke \< 3months * Creatinine \> 2 mg/dl * Relevant Liver disease (GOT \> twice the upper limit). * Anemia (Hemoglobin \<10 mg/dl) * Thrombocytopenia \< 100.000/µl * Allergies to Aspirin, Clopidogrel, Heparin * History of bleeding disorder * History of coagulopathy * Gastrointestinal Bleeding \< 3 months * Surgery or Trauma \< 2 months * Pregnancy * Mental Retardation * Participation in other clinical study \< 1 month